AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 115 filers reported holding AKERO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,010,572 | +81.8% | 59,521 | +67.8% | 0.00% | +100.0% |
| Q2 2023 | $1,656,281 | -32.9% | 35,474 | -45.0% | 0.00% | -33.3% |
| Q1 2023 | $2,468,420 | +19.3% | 64,517 | +70.9% | 0.00% | 0.0% |
| Q4 2022 | $2,069,248 | -99.6% | 37,760 | +158.3% | 0.00% | +200.0% |
| Q3 2022 | $497,743,000 | +135.2% | 14,618 | -34.7% | 0.00% | – |
| Q2 2022 | $211,661,000 | +126.7% | 22,398 | +240.3% | 0.00% | – |
| Q1 2022 | $93,384,000 | -22.5% | 6,581 | +15.5% | 0.00% | – |
| Q4 2021 | $120,470,000 | +12.3% | 5,696 | +18.7% | 0.00% | – |
| Q3 2021 | $107,235,000 | +359.3% | 4,798 | +409.9% | 0.00% | – |
| Q2 2021 | $23,346,000 | -53.3% | 941 | -45.4% | 0.00% | – |
| Q1 2021 | $49,955,000 | +45.7% | 1,722 | +29.6% | 0.00% | – |
| Q4 2020 | $34,288,000 | -63.9% | 1,329 | -56.9% | 0.00% | – |
| Q3 2020 | $94,864,000 | +785.3% | 3,081 | +616.5% | 0.00% | – |
| Q2 2020 | $10,716,000 | -79.6% | 430 | -82.6% | 0.00% | – |
| Q1 2020 | $52,470,000 | +320.6% | 2,475 | +340.4% | 0.00% | – |
| Q4 2019 | $12,474,000 | -9.2% | 562 | -7.0% | 0.00% | – |
| Q3 2019 | $13,741,000 | – | 604 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $179,296 | 57.03% |
| Redmile Group, LLC | 2,632,912 | $144,283,578 | 5.90% |
| Avidity Partners Management LP | 3,825,000 | $209,610,000 | 4.54% |
| COMMODORE CAPITAL LP | 537,076 | $29,432 | 4.44% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $32,564,955 | 3.92% |
| Paradigm Biocapital Advisors LP | 604,544 | $33,129,011 | 3.89% |
| Yiheng Capital Management, L.P. | 1,468,905 | $80,495,994 | 3.56% |
| Altium Capital Management LP | 125,000 | $6,850,000 | 3.48% |
| Tri Locum Partners LP | 128,851 | $7,061,000 | 2.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 172,100 | $9,431,080 | 2.70% |